McElhaugh Michael J.
SEC insider (Form 3/4/5 filer). CIK 0001635326. Interim President & CEO at Arbutus Biopharma Corp (ABUS). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 14, 2025. Located in WARMINSTER, PA.
Companies McElhaugh Michael J. has filed insider reports for
- Arbutus Biopharma Corp (ABUS): Director, Officer, Interim President & CEO
McElhaugh Michael J.
CIK: 0001635326
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABUS
Arbutus Biopharma Corp
DirectorOfficer